Boschert Jürgen M, Krauss Joachim K
Department of Neurosurgery, Mannheim University Hospital, Theodor-Kutzer-ufer 1-3, D-68167 Mannheim, Germany.
Clin Neurol Neurosurg. 2006 Feb;108(2):143-9. doi: 10.1016/j.clineuro.2005.03.006.
Endoscopic third ventriculostomy (ETV) is increasingly used for the treatment of shunt-related complications in hydrocephalic patients, particularly if the etiology of the underlying hydrocephalus is of obstructive nature.
Due to the slit-like configuration of the ventricles, ventricular dilatation must be achieved prior to ETV in patients with problems due to over-drainage. This has been accomplished by ligating or explanting the shunt. Here we present an alternative procedure using a gravitational antisiphon device.
In two patients with over-drainage due to shunted occlusive hydrocephalus ventricles were dilated by integrating an antisiphon device (Miethke ShuntAssistant, Aesculap AG, Tuttlingen, Germany) into their shunt systems. The resistance of the antisiphon device, which is available in configurations from 10 to 35 cm H2O was chosen 10 cm H2O higher than necessary to prevent siphoning in the individual patient.
Both patients gradually recovered from their over-drainage symptoms and the ventricles enlarged enough to allow access with an endoscope. Using a standard procedure, ETV was performed 7 days and 1 month later, respectively. In the same operative session the shunts were occluded. Shunts were removed within 6 weeks after ETV. During follow-up of more than 3 years, both patients remained free of symptoms.
The incorporation of an antisiphon device with resistance level selected 10 cm H2O higher than needed to prevent anti-siphoning into a pre-existing shunt system in patients suffering from shunt-related over-drainage is a safe and effective technique to render ventricles large enough to allow endoscopic access for ETV.
内镜下第三脑室造瘘术(ETV)越来越多地用于治疗脑积水患者的分流相关并发症,特别是在潜在脑积水病因是梗阻性的情况下。
由于脑室呈裂隙状结构,对于因引流过度而出现问题的患者,在进行ETV之前必须实现脑室扩张。这通常通过结扎或取出分流装置来完成。在此,我们介绍一种使用重力抗虹吸装置的替代方法。
在两名因分流性梗阻性脑积水导致引流过度的患者中,通过将抗虹吸装置(德国图特林根蛇牌公司的Miethke ShuntAssistant)集成到他们的分流系统中来扩张脑室。抗虹吸装置的阻力有10至35 cmH₂O多种规格可供选择,所选阻力比防止个体患者虹吸所需的阻力高10 cmH₂O。
两名患者均逐渐从引流过度症状中恢复,脑室扩大到足以允许使用内镜进入。分别在7天和1个月后,采用标准程序进行了ETV。在同一次手术中,分流装置被阻塞。ETV后6周内取出分流装置。在超过3年的随访期间,两名患者均无症状。
对于患有分流相关引流过度的患者,将阻力水平比防止反虹吸所需阻力高10 cmH₂O的抗虹吸装置纳入现有的分流系统,是一种安全有效的技术,可使脑室扩大到足以允许通过内镜进行ETV。